Hang Seng Hits 3-Yr. High
Hong Kong shares hit a three-year high Friday, leading gains in the region as investors weighed inflation data from Japan against tariff threats from U.S. President Donald Trump.In Japan, the Nikkei 225 index regained 98.9 points, or 0.3%, to 38,776.94. Japan’s inflation rate in January climbed to 4%, hitting its highest level since January 2023. Core inflation — which excludes prices of fresh food — rose to 3.2%, beating Reuters’ expectations of 3.1%.Investors will continue keeping an eye on the Japanese yen, which strengthened to a more than two-month high of 150.52 per U.S. dollar on Thursday amid bets of more rate hikes by the Bank of Japan this year. The currency is currently trading at 150.22 against the greenback.In Hong Kong, the Hang Seng index dropped 367.26 points, or 1.6%, to 22,576.98. its highest level since February 2022, according to data from LSEG. The Hang Seng Tech index added 6.15%. Shares of Hong Kong listed Alibaba rose 14.7% following a significant profit increase for the company in the December quarter, driven by growth in its Cloud Intelligence division and e-commerce sector.In other marketsThe CSI 300 in mainland China backpedaled 11.26 points, or 0.3% to 3,928.90In Taiwan, the Taiex index shed 116.62 points, or 0.5%, to 23,487.46.In Singapore, the Straits Times index gave back 6.53 points, or 0.2%, to 3,927.51In Korea, the Kospi index deleted 17.46 points, or 0.7%, to 2,654.06.In New Zealand, the NZX 50 subtracted 153 points, or 1.2%, to 12,880.36In Australia, the ASX 200 surrendered 96.37 points, or 1.1%, to 8,322.82.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


